236 related articles for article (PubMed ID: 38731910)
1. Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy.
Bhatt DK; Daemen T
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731910
[TBL] [Abstract][Full Text] [Related]
2. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
4. Combining oncolytic virotherapy and tumour vaccination.
Bridle BW; Hanson S; Lichty BD
Cytokine Growth Factor Rev; 2010; 21(2-3):143-8. PubMed ID: 20226716
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Immunotherapy.
Hennessy ML; Bommareddy PK; Boland G; Kaufman HL
Surg Oncol Clin N Am; 2019 Jul; 28(3):419-430. PubMed ID: 31079797
[TBL] [Abstract][Full Text] [Related]
6. A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment.
Chattopadhyay S; Hazra R; Mallick A; Gayen S; Roy S
Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189110. PubMed ID: 38754793
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic viruses for induction of anti-tumor immunity.
Tong AW; Senzer N; Cerullo V; Templeton NS; Hemminki A; Nemunaitis J
Curr Pharm Biotechnol; 2012 Jul; 13(9):1750-60. PubMed ID: 21740355
[TBL] [Abstract][Full Text] [Related]
8. Virus specific tolerance enhanced efficacy of cancer immuno-virotherapy.
Sobhanimonfared F; Bamdad T; Sadigh ZA; Choobin H
Microb Pathog; 2020 Mar; 140():103957. PubMed ID: 31891795
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Immunotherapy for Treatment of Cancer.
Tsun A; Miao XN; Wang CM; Yu DC
Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
[TBL] [Abstract][Full Text] [Related]
10. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy.
Shin DH; Nguyen T; Ozpolat B; Lang F; Alonso M; Gomez-Manzano C; Fueyo J
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795384
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation in Oncolytic Measles Virotherapy.
Dietz L; Engeland CE
Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.
Workenhe ST; Mossman KL
Mol Ther; 2014 Feb; 22(2):251-256. PubMed ID: 24048442
[TBL] [Abstract][Full Text] [Related]
13. Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy.
Niemann J; Woller N; Brooks J; Fleischmann-Mundt B; Martin NT; Kloos A; Knocke S; Ernst AM; Manns MP; Kubicka S; Wirth TC; Gerardy-Schahn R; Kühnel F
Nat Commun; 2019 Jul; 10(1):3236. PubMed ID: 31324774
[TBL] [Abstract][Full Text] [Related]
14. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.
Tian Y; Xie D; Yang L
Signal Transduct Target Ther; 2022 Apr; 7(1):117. PubMed ID: 35387984
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic viruses and immunity.
Chaurasiya S; Chen NG; Fong Y
Curr Opin Immunol; 2018 Apr; 51():83-90. PubMed ID: 29550660
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic viruses and their application to cancer immunotherapy.
Chiocca EA; Rabkin SD
Cancer Immunol Res; 2014 Apr; 2(4):295-300. PubMed ID: 24764576
[TBL] [Abstract][Full Text] [Related]
17. Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection.
Alvarez-Breckenridge CA; Choi BD; Suryadevara CM; Chiocca EA
Curr Opin Virol; 2015 Aug; 13():25-32. PubMed ID: 25846988
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic virotherapy: Challenges and solutions.
Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Virotherapy in Glioma Tumors.
Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
[TBL] [Abstract][Full Text] [Related]
20. Combination of virotherapy and T-cell therapy: arming oncolytic virus with T-cell engagers.
Song XT
Discov Med; 2013 Dec; 16(90):261-6. PubMed ID: 24333405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
